Find and Pitch Jounalists, Get Your Story Covered

Tags: Consumer / Employer, Daily, Health Tech, SYN, Top Story leadership pharma Boehringer Ingelheim Zeiss

	Profile	Recent Articles on Subject
1	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma - 16 days ago A Startup’s €90M Financing for Oral Peptide Drugs Includes Backing from Eli Lilly - about 2 months ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Angelini Ventures co-leads Series A financing in Neumirna Therapeutics - about 2 months ago
3	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Young biotech venture firm raises $500 million for its second fund - 3 months ago STAT+: Former NCI chief and serial biotech entrepreneur raise $70 million to start companies that fail fast - 3 months ago STAT+: Biotech startups post strongest financing numbers in two years - 11 months ago STAT+: Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline - 12 months ago STAT+: Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships - 12 months ago STAT+: Goldman Sachs launches $650 million fund for life sciences investments - about 1 year ago STAT+: Saudi VC loops Novo Nordisk, other biotech VCs into new longevity incubator - about 1 year ago STAT+: Biotech incubator Curie.Bio graduates its first startup - over 1 year ago STAT+: Life science investors close nearly $6 billion in new funds - over 1 year ago
4	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Sanofi pours $1 billion into China for insulin plant - 3 months ago Versant enters obesity with new startup - 3 months ago Element Biosciences raises another massive round - 8 months ago
5	Matthew Herper STAT News Writes at STAT. Biology's century. Undisclosed biologydatajournalism	STAT+: Former NCI chief and serial biotech entrepreneur raise $70 million to start companies that fail fast - 3 months ago STAT+: This chemist’s last startup sold for $4 billion. Now investors have poured $173 million into her next act - 12 months ago STAT+: Eli Lilly to pay $200 million for Beam’s share of drugs from gene-editing firm Verve - over 1 year ago
6	Mohana Ravindranath STAT News Health tech reporter at STAT. Oakland, CA + Washington, D.C. Health techreporting	STAT+: General Catalyst raises $8 billion, with $750 million for health care bets - 4 months ago STAT+: Venture capital firm General Catalyst wants to buy a health system - over 1 year ago
7	Adam Spatacco Motley Fool Community for top investors. Investingcommunity	This is Huge News For Eli Lilly Investors - 4 months ago
8	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Who’s winning in biotech’s tight market? - 5 months ago Neurvati touts fresh, ‘synergistic’ investment model in neuroscience R&D - 12 months ago
9	Linnea Ahlgren Next Web Senior Editor @thenextweb. 🌱-eater. Amsterdam, the Netherlands technologylifeediting	Balderton Capital announces $1.3B fund for European tech - 7 months ago German VC unveils record-breaking €214M early-stage fund for deep tech - 9 months ago
10	Zoya Mirza Utility Dive Journalist, Bibliophile, Foodie. New York, New York journalism	Bill Gates-backed energy investment firm pulls in $839M for new climate fund - 7 months ago

Journalists covering Boehringer Ingelheim Venture Fund \